Design the generic ophthalmic solutions clinical trials [Design Issues]

posted by ElMaestro  – Denmark, 2012-01-20 09:31 (5257 d 07:45 ago) – Posting: # 7971
Views: 2,565

Hi Gore,

All the ophthalmic solutions come in the bottle, which are produced with the specific chemical ingredients, colours and dimension with shape.


In such cases if we are the generic developer how to conduct clinical trial and it’s blinding when the competitor ophthalmic preparation available in the patented bottle only?


How about double dummies? You take the originator's bottle, empty it and fill it with placebo. Each patient then gets X drops from the generic (verum or placebo) and X drops from the originator (verum or placebo) per period.

Best regards,
EM.

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
114 visitors (0 registered, 114 guests [including 18 identified bots]).
Forum time: 18:16 CEST (Europe/Vienna)

Outside his own ever-narrowing field of specialization,
a scientist is a layman.
What members of an academy of science have in common
is a certain form of semiparasitic living.    Erwin Chargaff

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5